News
The medtech company has obtained provisional authorization from Singapore’s HSA for its rapid test kit to be used in Singapore.
The funds will be used for the telehealth startup’s expansion in the APAC region with the support of local and regional partners.
Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.
Users can choose from 100 conditions and get information about telemedicine pricing and medication services.
This builds on a $500,000 dollar seed round announced last May.
COVID-19
The platform enables healthcare professionals to conduct video appointments with remote patients.
The new website and app were born out of a partnership with Apple, the CDC, the White House Coronavirus Task Force and FEMA.
Both efforts are employing popular consumer wearables and health trackers to spot potential cases of COVID-19 or other viral diseases as they begin.
Dr. Yuri Maricich, chief medical officer at Pear Therapeutics, speaks on his company's experience bringing a digital therapeutic product through the regulator's experimental program for health software.
The simple finger-prick test will be made available first to NHS staff.